Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial
- B. V. Loughrey; A. McGinty; I. S. Young; D. R. McCance; L. A. Powell Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial Clinical endocrinology